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Bioelectric-calcineurin signaling
module regulates allometric growth
and size of the zebrafish fin
Jacob M. Daane1, Jennifer Lanni1,2, Ina Rothenberg3, Guiscard Seebohm3, Charles W. Higdon4,
Stephen L. Johnson4 & Matthew P. Harris1
The establishment of relative size of organs and structures is paramount for attaining final form and
function of an organism. Importantly, variation in the proportions of structures frequently underlies
adaptive change in morphology in evolution and maybe a common mechanism underlying selection.
However, the mechanism by which growth is integrated within tissues during development to achieve
proper proportionality is poorly understood. We have shown that signaling by potassium channels
mediates coordinated size regulation in zebrafish fins. Recently, calcineurin inhibitors were shown to
elicit changes in zebrafish fin allometry as well. Here, we identify the potassium channel kcnk5b as a
key player in integrating calcineurin’s growth effects, in part through regulation of the cytoplasmic
C-terminus of the channel. We propose that the interaction between Kcnk5b and calcineurin acts as
a signaling node to regulate allometric growth. Importantly, we find that this regulation is epistatic
to inherent mechanisms instructing overall size as inhibition of calcineurin is able to bypass genetic
instruction of size as seen in sof and wild-type fins, however, it is not sufficient to re-specify positional
memory of size of the fin. These findings integrate classic signaling mediators such as calcineurin with
ion channel function in the regulation of size and proportion during growth.
The establishment of relative proportion of structures and organs is essential for the normal physiology and
function of an organism. The study of differential growth of structures in development and in the evolution
of form has a rich history1. A key advance in our understanding differential growth stems from the work of
D’Arcy Thompson and his efforts to define the underlying rules of coordinated transformations in form2. This
foundational work was leveraged by Huxley and Teissier who formalized scaling relationships between structures within organisms as a power law that details the relative proportion of structures3,4. This law provides a
scale-independent means of comparing growth in development and among species.
A common mechanism for the establishment of organ size and the relative proportions of structures is
through differential sensitivity of organs to a systemic growth signal such as insulin-like growth factors (IGF)
or growth hormone (GH)5,6. However, there is substantial evidence for an organ-intrinsic capacity to establish
relative size that is robust to such broad systemic signals. Transplanted organs will frequently reach their target size even when cultured in ectopic locations7–9. Intrinsic regulation of size in structures is also observed
in cases in which organs will accelerate growth back to a seemingly pre-ordained growth trajectory following
growth-limiting insults, such as nutrient deprivation or illness10,11. This “catch-up growth” is also seen during
epimorphic regeneration, wherein growth rate is dependent on the amount of tissue lost such that recovery of the
original form occurs within the same time window; this suggests that relative growth rates are guided by retained
positional cues within tissues12–15. How growth is integrated with positional information within the organ to
achieve proper proportion remains unclear.
An effective strategy to understand growth and regulation of size is to analyze mutants or experimental conditions in which scaling properties have been altered. Through genetic screens in the zebrafish, several mutants
have been identified that have adult fins that are reduced in size as well as mutants in which fins grow beyond their
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normal limit16–23. The another longfin mutant was identified as having enlarged fins and barbels24. We have previously shown that alf is caused by a specific gain-of-function point mutation in the potassium channel kcnk5b, a
member of the TWIK/TASK two pore family (K2P) of potassium channels20. Supporting a role for ion regulation
in establishing proportion, the shortfin (sof) mutant has been mapped back to mutations in the gap junction connexin43 (cx43/gja1)18,25. Though both gap junctions and potassium channels have important roles in physiology
and cell biology, these initial findings in the zebrafish fin are surprising in that they uncover a specific role for
local bioelectric signaling in the regulation and coordination of growth.
Insight into the mechanisms regulating coordinated growth also comes from pharmacological regulation of
cell signaling during development. Inhibition of calcineurin in developing and regenerating fins by FK506 and
cyclosporin A specifically increases the size of the resulting fin26. Calcineurin is a protein phosphatase known to
affect transcription through direct binding and dephosphorylation of the NFAT family of transcription factors27.
Analysis of the patterning and gene expression profiles in overgrown fins treated with FK506 led Kujawski and
colleagues to suggest that positional information of the fin was specifically altered by calcineurin inhibition.
Under this hypothesis, activation of calcineurin triggers a proximal-like growth program that leads to enhanced
proliferation to re-specify larger fin sizes26.
Here, we extend analysis into mechanisms of size regulation by potassium channels and calcineurin using
the zebrafish fin as a model. We show that FK506 can mirror the growth effects of activated Kcnk5b, and can
override genetic determination of size. Importantly, we demonstrate that Kcnk5b function is a key component to
the ability of FK506 to regulate growth. Through our genetic and experimental analyses, we demonstrate that the
growth-mediating properties of FK506 do not re-specify positional memory in the fin, but rather act to maintain
heightened rate of growth during regeneration of the fin. These data advance our understanding of how size is
regulated during growth and provide a regulatory link between bioelectric and classical signaling pathways in the
regulation of growth and proportion.

Results

Skeletal phenotypes of fins treated with FK506 compared to mutants affecting fin proportion.

Fins are composed of multiple segmented rays of dermal bone. Elongation of the fin occurs through sequential
addition of these bony segments to the distal fin tip. The zebrafish fin-ray segments are regularly patterned such
that each segment is of roughly same length along the proximal-distal axis. While the segmentation pattern of the
fin rays can be dissociated from total fin length28, mutants with altered fin size are often accompanied by a change
in size of segments, consistent with alterations in the rate of growth17,20,25. The fin segments in kcnk5b/alf mutant
are generally elongated, while those of the shortfin mutant are shorter18,20 (Fig. S1).
As segmentation patterns are influenced by mutations that alter fin size, we asked whether FK506 treatment
had an effect on segmentation patterning. We focused primarily on fin regeneration, which recapitulates growth
properties that occur during fin development. During fin regeneration, both the missing fin tissue and segmentation patterns are precisely restored. Thus, regeneration assays can serve as a foundation for exploring the genetic
contributions of positional identity and memory, growth rate, and patterning. Treatment of regenerating fins
with the calcineurin inhibitors FK506 and cyclosporin A led to dose-dependent coordinated overgrowth of fin
regenerates (Fig. S1E)26. FK506-treated fins also exhibited elongated fin ray segments, similar to those observed
in kcnk5b/alf mutants (Fig. S1E–G). Surprisingly, FK506 treatment of cx43/shortfin regenerating fins also resulted
in elongated fin ray segments (Fig. S1H).

FK506 treatment regulates growth independently of memory of size. As treatment of fins with
FK506 appears to bypass the genetic specification of normal fin length in wild-type fish26, we sought to define
the growth characteristics of inhibiting calcineurin in the background of different mutants with altered fin size.
Similar to wildtype, when cut to 50% of their initial size, the fins of short-finned (cnx43/sof) and long-finned
(kcnk5b/alf) fish regenerate back to their pre-amputation size over a similar time period despite their vastly different starting lengths (Fig. 1). However, FK506-treatment of regenerating fins from both wild-type and cnx43
short-finned mutants leads to an increased rate of growth in each group, resulting in the formation of similarly sized, larger fins in both genotypes (Fig. 1). Oddly, the shape and size of FK506-treated fins from cx43/sof
mutants were indistinguishable from treated wild-type fins (Fig. S1H). Of note, FK506-treatment of fish with
gain-of-function of kcnk5b activity does not lead to an additional increase in the size of the regenerate or rate
of its growth over untreated mutants (Fig. 1). All fins treated with FK506 regrow at comparably increased rates,
regardless of genotype or previous size. These data suggest that the effect of calcineurin on fin growth is acting
at, or downstream of, mechanisms specifying size. Further, the phenotypic similarities between alf and those of
FK506-treated fins raise the potential that these two mechanisms may be integrated.
Kcnk5b activity is critical for growth effects of FK506.

Fish deficient for kcnk5b have normal fin proportions and growth20. To assess the role of Kcnk5b in calcineurin growth regulation, we resected the pectoral fins of kcnk5b−/− fish and asked if the channel is needed for the FK506 growth response. Unexpectedly, the
growth effects driven by FK506 treatment are suppressed in kcnk5b−/− fish (Fig. 2A–C). This effect was seen in
both pectoral fin as well as caudal fin regeneration (Fig. 2D). These data reveal that Kcnk5b is a critical component of FK506-mediated regulation of growth and size. Some additional growth occurs after FK506 treatment in
kcnk5b−/− fish, raising the possibility that residual function of the kcnk5a paralogue or other targets of FK506 may
contribute in part to the FK506 response.

Modification of kcnk5b function by calcineurin.

Kcnk5b could mediate FK506 growth effect indirectly or through modification of calcineurin regulation. Increasing the levels of wild-type kcnk5b locally in the
fin is sufficient to induce fin overgrowth20. As large changes in transcription are observed in regenerating fins
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Figure 1. Calcineurin inhibition is sufficient to override genetic encoding of size. (A) Regenerative growth
of zebrafish pectoral fins after resection to ~50% of pre-cut fin length at 0 days post amputation in different
genetic backgrounds with short- (cx43sof/sof) or long- (kcnk5balf) fin size relative to wild-type fish. Dashed lines
indicate pre-cut pectoral fin length. Data normalized to standard length (STL) of each fish. ANOVA genotype
by treatment interaction test F(2,23) = 27.89, p < 0.0001. Pairwise comparisons (ANOVA p-value): alf FK506alf DMSO (1.0), alf DMSO-sof FK506 (0.25), alf DMSO-wt FK506 (0.25), wt FK506-sof FK506 (1.0), sof FK506sof DMSO (<0.0001), wt FK506-wt DMSO (0.0013). (B) Representative ventral view of pectoral fins after
regeneration. Black line indicates unoperated pectoral fin length. Red line indicates pectoral fin length after
treatment with FK506 during regeneration. Black dashed line highlights site of amputation. Growth rate of
FK506-treated regenerating caudal fins. (D) Caudal fins were resected to 50% of their original size and treated
with FK506. Growth rate is analyzed through 9 days post amputation, when regenerative growth rate for DMSO
treated fins begins to slow. Two-tailed t-test p < 0.0007 for suppression of growth in the absence of kcnk5b. Error
bars represent ± SEM.

treated with FK50626, we hypothesized that FK506 mediated overgrowth could be due to upregulation of kcnk5b
expression levels. However, we find that expression of kcnk5b is not significantly altered in wild-type regenerating
fins after FK506 treatment (Fig. 3A). To test the potential for direct modulation of channel activity by FK506/
calcineurin, we assessed the change in conductance of Kcnk5b channel variants in Xenopus oocytes. Oocytes
expressing wild-type zebrafish Kcnk5b show decreased conductance when treated with FK506 (Fig. 3D,E; see
Nam et al.29). Similarly, treatment of oocytes expressing kcnk5b with VIVIT, an independent peptide inhibitor
of calcineurin, showed a comparable decrease in conductance, supporting a role of calcineurin in regulation of
channel activity (Fig. 3E inset).
It has been shown that the activity of another KCNK two-pore potassium channel family member, Kcnk18/
TRESK, is regulated by direct binding of calcineurin to the intracellular loop of the channel. This binding affects
downstream dephosphorylation events on conserved serine residues on the C-terminus of the channel 30,31.
Intriguingly, we identified a putative calcineurin binding site in the cytoplasmic C-terminus of zebrafish Kcnk5b
that is similar to that identified in KCNK18/TRESK (Fig. 3B). Czirják et al. previously demonstrated that an isoleucine to alanine mutation in this domain in TRESK attenuated the effect of calcineurin and its binding to the
channel30. We mutated the co-responding residue in the presumptive binding site in Kcnk5b (I290A; Fig. 3B) and
assessed the effect on conductance of the channel in oocytes. Oocytes expressing Kcnk5b/I290A had lower conductance than wildtype, but were similar to wild-type channels treated with FK506 (Fig. 3C–E). Importantly, the
Kcnk5b/I290A expressing oocytes were also non-responsive to FK506 treatment. Thus, the effect of the altering
the molecular characteristics of this site on the Kcnk5b C-terminal intracellular domain is comparable in effect to
chemical inhibition of calcineurin by FK506. This result suggests that, similar to KCNK18, the activity of Kcnk5b
is modulated by calcineurin through interactions with the cytoplasmic C-terminus.
The alf mutation affects the last transmembrane domain of the channel located just prior to the predicted
calcineurin binding site (Perathoner et al.20, Fig. S3). In an effort to screen for further variants affecting growth
within this region, we used CRISPR-targeted Cas9 genetic editing with guides targeted to the fifth exon of kcnk5b,
which contains the transmembrane and C-terminus, and screened adults for somatic clones sufficient to cause
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Figure 2. Kcnk5b mediates the effect of calcineurin in regulating proportion. (A) Example of growth of
pectoral fins of wildtype or kcnk5b deletion mutants regenerating after treatment with FK506. Dashed line
indicates plane of section; black bar extent of growth of untreated fin; red, resected fin. (B) Growth rates of
wildtype and kcnk5b deficient zebrafish. Dashed line, size of original pre-cut fin. Error bars represent ± SEM.
ANOVA genotype by treatment interaction F(1,45) = 6.59, p = 0.014. Pairwise comparisons (ANOVA p-value):
kcnk5b−/− FK506-wt FK506 (0.0013), kcnk5b−/− DMSO-wt DMSO (1.0), kcnk5b−/− FK506-kcnk5b−/− DMSO
(0.022). (C) Growth rate of regenerating fins of different kcnk5b genotypes treated with FK506. Gray dots
represent individual fish. Two-tailed t-test p < 0.0002 for suppression of growth in the absence of kcnk5b. Data
is from four independent experiments. (C) Representative ventral view of pectoral fins after regeneration.

overgrowth. We recovered fish having overgrowth caused by guides targeting the transmembrane region of the
channel. Analysis of Kcnk5b in these clones revealed formation of frameshift mutations leading to early termination (Fig. S3). Thus, loss of the last transmembrane domain and the cytoplasmic tail of Kcnk5b is sufficient to
lead to increased proportion.

Calcineurin signaling does not re-specify positional cues, rather overrides them.

We have
demonstrated an interaction between Kcnk5b and calcineurin-mediated signaling in regulating growth. However,
the ability of this module to specify growth or identity of the fin remains unclear. Kujawski et al.26 provide
evidence of perdurance of proximal markers in treated fins and suggest that calcineurin inhibition leads to a
re-specification of the regenerating tissue to a proximal identity. However, these data are also consistent with
the hypothesis that the treatment leads to a sustained increase in the rate of growth that then is associated with
broader domains of regional markers in the enlarged regenerated tissue. To address the effect of calcineurin on
altering positional information of the fin, we mirrored classic experiments of Maden (1982)32 in regulation of
positional identity of limb regenerates in the salamander and asked if limited alteration of calcineurin could
respecify identity of the fin regenerate and thus its interpretation of fate.
We first approached this question by addressing how fins respond when FK506 is removed. Pectoral fins
regenerating under the influence of FK506 exhibited increased growth (Figs 2 and S1). However, after removal
of the drug, either prior to achieving their original size, or in fins that had surpassed their original size, regenerative growth quickly stopped regardless of the extent of the fin regenerate (Fig. 4A). Thus, FK506 induces an
acceleration of growth that requires continual presence of the drug for sustained overgrowth. We extended these
studies to address if the identity of the regenerated tissue was altered by treatment with FK506. As amputated
fins will regenerate back to a size similar to that originally specified during development, the fin tissue remaining
after amputation retains information concerning size and proportion that is then integrated in the regenerate.
However, if overgrown fins caused by FK506 inhibition of calcineurin are resected, either into the original fin
tissue or within a regenerated portion of the fin, these resulting regenerates grew only to the original size of the
SCientifiC REPOrTS | (2018) 8:10391 | DOI:10.1038/s41598-018-28450-6
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Figure 3. FK506 effect on Kcnk5b activity is modulated by the cytoplasmic domain of the channel. (A) qRTPCR comparing relative levels of kcnk5b in FK506-treated, 5-day post-amputation pectoral fin blastemas
to values of DMSO-treated controls (n = 5, ±SEM). (B) Multiple sequence alignment of Kcnk5b protein
highlighting putative calcineurin binding domain with resemblance to calcineurin binding in TRESK
(red bar, PQIVID30 and a nearby suite of highly conserved serine residues (green bars). Asterisk indicates
site of mutagenesis in (C–E) (I290A). Alignment generated by MUSCLE55. Diagram adapted from56. (C)
Representative electrophysiology current traces from voltage clamp recordings in Xenopus oocyte injected with
wild-type or mutant I290A Kcnk5b cRNA and treated with FK506 or DMSO. The membrane potential was
clamped at a reference potential of −80 mV and then varied by incremental 20 mV steps to a range of −100 mV
to +60 mV. (D) Current is suppressed in wild-type Kcnk5b homodimers through treatment with FK506 or by
mutation of the calcineurin binding site (I290A). (E) Recorded currents were normalized to the value recorded
for oocytes injected with the wild-type channel at +60 mV. Inset, Xenopus oocytes expressing wild-type
zebrafish Kcnk5b were injected with VIVIT peptide or carrier. Patch clamp experiments registered the resulting
conductance. **p < 0.001, n, number of oocytes assessed.

Figure 4. Calcineurin inhibition establishes regenerative growth rate independently of positional identity.
(A) Pulse of FK506 treatment for 6 or 14 days post-amputation to assess effects of transient inhibition of
calcineurin by FK506 on growth and patterning of the fin. Fins were cut to 50% original length and allowed to
regenerate in the presence of FK506. Arrows indicate end of drug treatment (n = 5 fish per treatment group).
(B) Subsequent regeneration of the pectoral fins from (A) in the absence of FK506 after resection at original
cut site to determine if fin allometry was re-set to a larger size through previous FK506 treatment. (C) Second
regeneration of FK506-treated fins cut at a site within the regenerated tissue demonstrating memory of original
positional information and recovery of wild-type size within the pectoral fin. Gray dashed line indicates pre-cut
fin length. Red dashed lines indicate second resection. Error bars represent ± SEM.
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fin prior to treatment with FK506 (Fig. 4B,C). Similarly, FK506-treated overgrown fins cut beyond the original
wild-type fin length failed to grow further upon amputation without the presence of the drug (Fig. 4C). Similar
effects were seen in when tested in both pectoral as well as caudal fin regenerates (Fig. S2). Thus, Kcnk5b/calcineurin signaling does not lead to lasting alterations in positional identity, but rather regulates rate of growth
leading to enhanced fin proportions.

Discussion

Bioelectric integration of growth and form. Bioelectric potential is manifest as a resting voltage state of
cells (Vmem). While it is clear that specialized cells such as nerves and cardiomyocytes have honed the regulation
of electrical potential for specific functions, a broader role of this signaling in development and homeostasis is
becoming apparent as it is necessary for normal pattern and growth of diverse organ systems33–37. Natural and
experimental changes of resting potential can have broad effects in morphogenesis. A key property of bioelectric
signaling is the capacity to coordinate responses across cells and tissues. Many tissues are electrically coupled
through the action of gap junctions, and localized signals can expand via paracrine signaling by local fluctuations
in electrical fields38. Thus, the integration of cellular- and tissue-level responses to inductive signals as well as
integration of patterning cues within developing organs can be orchestrated though electrical coupling of cells
such that a unified structure is formed and maintained. Perturbations of such electrically coupled-developmental
systems could be a factor for the coordinated transformations observed in evolution2,39 and broad patterning
phenotype observed in some diseases 37,40. The role of kcnk5b in regulation of proportion was identified in genetic
screens through its actions in causing altered scaling properties of adult fins (Perathoner et al.20). We show that
Kcnk5b is a key component to increased fin growth caused by calcineurin inhibition. Importantly, our work here
demonstrates that Kcnk5b/calcineurin signaling is sufficient to increase growth regardless of innate size and genotype and thus override, but not re-specify, positional identity of the fin.
We demonstrate that Knck5b, like Kcnk18, can signal through calcineurin via a region in its C-terminus.
Altering the presumptive binding site on the C-terminus of Kcnk5b (I290A) is sufficient to mirror the effect of
calcineurin inhibition and to remove sensitivity to FK506 treatment for conductance. FK506 treatment of Kcnk5b
in oocytes leads to decreased current. Similarly, the I290A mutation also mirrors this response. In contrast, alf
mutants20 show increased conductance in oocytes. This difference of the direction of conductance with similar
growth outcomes may also point to the importance of signaling events downstream of changes in conductance
that drive fin growth. The C-terminus of mouse Kcnk5/TASK-2 interacts directly with Gβγ subunit of heterotrimeric G-proteins41, and work on other two pore potassium channels, such as TREK-1 and TREK-2, has revealed
dynamic regulation by cAMP/PKA, DAG/PIP/PKC and nitric oxide/cGMP/PKG pathways42. Modulation of
Kcnk5b activity by conductance, or through interactions with its C-terminus, may act to adjust and/or respond to
changes in voltage to regulate growth rate. Interestingly, we have found that premature truncation mutations leading to channels that lack the last transmembrane domain and the C-terminus of Kcnk5b result in fin overgrowth
comparable to that seen in the alf mutant, which affects the identical region (F241Y, Fig. S3). As null alleles of
kcnk5b do not cause an overgrowth phenotype, the truncation mutation appears to cause an increase in function
of the channel. Alteration of the pore structure or conformation/presence of the C-terminus may cause dysregulated channel activity leading to overgrowth. The regulation of calcineurin may reflect downstream response to
changes in conductance or conformation and thus, link calcium signaling to changes in pore conductance and/or
conformation. In support of these findings, there is evidence that polarization-dependent differentiation of myoblasts requires calcineurin function in a manner that is sensitive to dephosphorylation of the Kir2.1 channel43,44.
Thus, integrated bioelectric and secondary signaling mechanisms may have broader roles in development and
physiology that previously expected.
Coordination of growth and proportion. Regulation of overgrowth by Kcnk5b/calcineurin signaling is

coordinated among diverse tissues of the developing and regenerating fin to establish a larger, functional structure. This coordination may be attained through a re-interpretation of positional information within the fin such
that regenerating tissues replace the missing components with tissue in register with the distal edge of the remaining fin stump. Positional information within the fin may be set up and driven by differential gene expression
patterns in development45,46. Rabinowitz et al.46 detail expression profiles of wild-type fins that support dynamic
regulation of gene expression across the proximal-distal aspect of the fin. Interestingly, a significant class of genes
differentially isolated in these studies was ion channels, suggesting that bioelectric signaling may be a key factor
of this asymmetry and establishment of positional cues. The work on calcineurin by Kujawski et al.26 also would
point to calcineurin signaling as mediating position and being able to re-specify identity when altered. This mechanism was founded on extended gene expression domains in the proximal component of the fin and delayed
distal bifurcation of the rays after calcineurin inhibition. However, an alternate explanation for the observed
changes in pattern is that the expanded proximal molecular and anatomical identities observed in FK506-treated
fins are a consequence of increased growth rate, such that larger regional domains, interpreted as position, are
generated rather than specific changes in identity per se. This hypothesis would explain observed overgrowth as
well as extended branching of the fin, but would be independent of changes in positional memory. Alternatively,
positional information is independent of size-instructive signals suggesting that modification of identity markers
stemming from Kcnk5b/calcineurin signaling is coincident, but independent from, mechanisms of size determination and relative proportion.
Our data link the growth regulation of Kcnk5b and calcineurin and demonstrate that their function is not sufficient to re-specify identity, rather to override it. Establishing, or re-establishing, identity in the fin may require
signals present only during development and may not be malleable during regeneration. Long-term treatment of
fish during development with FK506 leads to global alterations in growth of the body that make comparison of
proportion difficult (Fig. S4). Thus, identification of these developmental cues to regulate proportion and size will
SCientifiC REPOrTS | (2018) 8:10391 | DOI:10.1038/s41598-018-28450-6
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require dissociation by other means. Our findings suggest that the regulation of growth by Kcnk5b/calcineurin
fulfills the general requirements of a scaling property previously defined by relative growth comparisons and
represented by the rate constant of Huxley and Teissier (1939). The encoding and specification of absolute size,
however remains undefined.

Methods

Fish Husbandry.

The zebrafish AB strains and Tübingen (Tü) strains carrying albino mutation were used
as background for all experiments. Fish were bred and maintained as previously described47. All experimental
procedures involving fish conform to AAALAC standards and were approved by institutional IACUC committees. A complete description of the husbandry and environmental conditions in housing for the fish used in these
experiments is available as a collection in protocols.io https://doi.org/10.17504/protocols.io.mrjc54n.
For all experiments, adult stages defined by reproductively mature fish >3 months old were used for analysis.
Mutant alleles used in this work are alf dt30mh, sof dj7e2, and kcnk5b j131x8.

Fin Regeneration and Measurements.

Fish were anesthetized by treatment with tricaine for measurements and pectoral fin amputation. Unless otherwise indicated, pectoral fins of wildtype and mutants were
resected to roughly 50% their pre-cut length using standard surgical scissors. Fin length was measured before,
during and after regeneration using handheld calipers and measurements were normalized to the fish standard
length, determined as the length from the tip of the snout to the posterior end of the caudal peduncle. Fin growth
rate was measured for individual fish as the slope of the linear growth regression line over time from the amputation stump through the cessation of growth. Regeneration was considered complete for both treatment groups
when the DMSO-treated control fins stopped growing (~3 weeks). ANOVA was used to compare mean fin growth
of the genotypes and FK506 treatment groups. A genotype by treatment interaction test assessed whether the
effect of FK506 was similar in all genotypes. Post-hoc pairwise comparisons between groups were adjusted for
multiple comparisons using the Tukey-Kramer method. Analysis was done with SAS 9.4 (Cary, NC).

FK506 Treatment. Stock FK506 (Sigma) was dissolved in dimethyl sulfoxide (DMSO; Sigma). Fish water
was treated with 100 nM FK506 unless otherwise indicated. Up to five individual zebrafish were housed in 1 L of
FK506- or DMSO-treated fish water and were fed daily with live artemia. Water and drug were refreshed every
other day throughout the duration of the experiment.
qRT-PCR.

Five days post amputation, pectoral fin regenerates were collected from five individuals of each
treatment group. For RNA extraction, tissue was homogenized in TRIzol Reagent (Invitrogen). cDNA synthesis was performed with oligo dT primers using SuperScript III Reverse Transcription Kit (Invitrogen).
qRT-PCR was performed with Power SYBR Green Master Mix (Applied Biosystems) on Applied Biosystems
ViiA 7 Real Time PCR System. Cycling conditions: 10 minutes at 95 °C; 40 cycles of 15 seconds at 95 °C followed by 1 minute at 60 °C; melting curve analysis with 15 seconds at 95 °C, 1 minute at 60 °C and 15 seconds
at 95 °C. Temperature was varied at 1.6 °C/s. Expression levels were normalized relative to β-actin. ddCt was
used to calculate fold change in FK506-treated relative to the average of DMSO-treated fish. Kcnk5b primers:
5′-TTGTAGCCGTCTGTGACCAA-3′, 5′-AGTACCGCACCCAAACTGTC-3′. β-actin primers: 5′-CAACAACC
TGCTGGGCAAA-3′, 5′-GCGTCGATGTCGAAGGTCA-3′.

Electrophysiology.

The cDNA of Kcnk5b was subcloned into pSGEM for cRNA expression. The plasmid
was linearized using NheI and cRNA was in vitro synthesized using the T7 mMessage mMachine kit (Ambion).
Xenopus laevis oocytes were provided by Ecocyte Bioscience. Oocyte handling, injection and electrophysiological
recordings were as previously described48. Briefly, stage V oocytes were injected with 4 ng of cRNA encoding
wildtype or mutant I290A kcnk5b and stored for 3 days at 18 °C in Barth’s solution containing (in mmol/L): 88
NaCl, 1.0 KCl, 2.4 NaHCO3, 0.33 Ca(NO3)2, 0.4 CaCl2, 0.8 MgSO4, 5 Tris-HCl, penicillin-G (63 mg/L), gentamicin (100 mg/L), streptomycin sulfate (40 mg/L), theophylline (80 mg/L); pH 7.6. Two-electrode-voltage–
clamp recordings were performed at 22 °C using a Turbo Tec-10CD amplifier (NPI electronics), Digidata
1322 A AD/DA-interface and pCLAMP 9.0 software (Axon Instruments Inc./Molecular Devices). Before
measurement oocytes were pre-incubated in 0.5% DMSO (control) or in 50 µM FK506 (InvivoGen) for 1 h at
18 °C in ND96 recording solution containing (in mM): 96 NaCl, 4 KCl, 1.8 MgCl2, 1.0 CaCl2, 5 HEPES; pH
7.6. FK506 was dissolved in DMSO and FK506 dilution in ND96 was prepared freshly before every experiment. Recording pipettes were filled with 3 M KCl and had resistances of 0.5–1.5 MΩ. Data were analyzed
with Clampfit 9.0 (Molecular Devices Corporation), Excel (Microsoft) and Prism6 (GraphPad Software).
p-values were corrected for multiple hypothesis testing using Bonferroni test in Origin software (OriginLab,
Northampton, MA). The Kcnk5b I290A variant was generated by QuikChange II (Agilent). Mutagenesis primers:
5′-CTCGCTCTGGAGTCGCTGACATCTTTGAG-3′, 5′-CTCAAAGATGTCAGCGACTCCAGAGCGAG-3′.

CRISPR generation of kcnk5b somatic clones. The fifth and terminal exon of zebrafish kcnk5b encodes

the last transmembrane domain and cytoplasmic C-terminus. We designed guide RNAs (gRNA) tiling this exon
to screen for sufficiency of deletions in this region to affect fin growth in mosaic injected animals. The ChopChop
online was used to design gRNAs to limit predicted off-target gRNA cutting49,50. The pool of 5 distinct gRNAs
were simultaneously injected to blanket the start of the exon. These gRNAs were assembled according to Gangon
et al.51. Briefly, oligos containing the gRNA target were annealing to a universal oligo containing the tracrRNA
and SP6 promoter. The annealed oligo ends were then filled in with T4 polymerase for 20 minutes at 12 °C. gRNA
was synthesized from this oligo template using Ambion MEGAscript SP6 Kit. For transcription efficiency, the first
two bases of each gRNA were changed to ‘GG’ as there is evidence that these bases have less effect on Cas9 cutting
efficiency or off-target binding than mutations closer to the PAM site52–54. gRNAs were injected into single cell
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zebrafish embryos at a concentration of 50 ng/μl blanket and 300 ng/μl Cas9. To screen for deletion efficiency, the
target exon was amplified from pools of three 24 hour embryos and the resulting amplicons were heated to 95 °C
and cooled at −0.1 °C per second to form heteroduplexes. Following heteroduplex PCR, a T7 endonuclease digestion for 30 minutes at 37 °C in NEB Buffer 2 was used to generate deletions in the presence of Cas9-induced indels.
Primers for colony PCR cloning of the exon 5 screen: 5′-GGCAAATCAAACTGGTTAGTCC-3′, 5′-CGCTGTAG
TCCTCGACCTTC-3′. gRNA sequences: 5′-ATCACTTTGTTTCCATACAG-3′, 5′-GACAAAGAA
TCTGTAGAGAG-3′, 5′-GGATCTACCTGGGCCTTGCT-3′, 5′-TTGGAACGTGCATATGGTGG-3′, 5′-CGTCAT
GGTGGGCAGCCTG-3′.

Significance Statement.

The diversity of forms in Nature is frequently derived from variation in the
proportions of organs and tissues. The ability of organs and tissues to attain proper proportions is generally
unknown. Recent work has shown that inhibition of the activity of calcineurin modulates size of fins in zebrafish.
Here, we show that the action of a potassium channel, Kcnk5b is required for growth caused by calcineurin inhibition. Importantly, we show that these factors specify fin growth independently from inherent cues of size and
positional identity of the fin. Our work shows that this signaling node acts as a molecular rheostat, able to integrate bioelectric and calcium-mediated signaling systems to dial relative growth rates guiding ultimate fin size.
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